Comprehensive Analysis of Transcriptome Variation Uncovers Known and Novel Driver Events in T-Cell Acute Lymphoblastic Leukemia
暂无分享,去创建一个
Stein Aerts | Gert Hulselmans | Frank Speleman | Jan Cools | Robin Foà | Peter Vandenberghe | Ellen Geerdens | Anne Uyttebroeck | Sabina Chiaretti | Arun George Devasia | Kaat Durinck | Jacqueline Cloos | S. Aerts | F. Speleman | R. Foà | S. Chiaretti | Gert Hulselmans | Zeynep Kalender Atak | J. Cools | V. Gianfelici | E. Geerdens | N. Mentens | J. Cloos | A. Uyttebroeck | P. Vandenberghe | K. De Keersmaecker | K. Durinck | Zeynep Kalender Atak | Valentina Gianfelici | Kim De Keersmaecker | Nicole Mentens | Iwona Wlodarska | A. G. Devasia | I. Wlodarska | Gert J. Hulselmans
[1] B. Göttgens,et al. Bivalent promoter marks and a latent enhancer may prime the leukaemia oncogene LMO1 for ectopic expression in T-cell leukaemia , 2013, Leukemia.
[2] Tyson A. Clark,et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array , 2006, BMC Genomics.
[3] T. Waldmann,et al. FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma. , 2011, Blood.
[4] Andrew P. Weng,et al. Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia , 2004, Science.
[5] Elizabeth M. Smigielski,et al. dbSNP: the NCBI database of genetic variation , 2001, Nucleic Acids Res..
[6] E. Clappier,et al. Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia , 2008, The Journal of experimental medicine.
[7] Lee T. Sam,et al. Transcriptome Sequencing to Detect Gene Fusions in Cancer , 2009, Nature.
[8] Stein Aerts,et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia , 2012, Nature Genetics.
[9] Paul Pavlidis,et al. Assessing identity, redundancy and confounds in Gene Ontology annotations over time , 2013, Bioinform..
[10] A. Ferrando,et al. Oncogenic IL7R gain-of-function mutations in childhood T-cell acute lymphoblastic leukemia , 2011, Nature Genetics.
[11] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[12] Lior Pachter,et al. Identification of novel transcripts in annotated genomes using RNA-Seq , 2011, Bioinform..
[13] Xuexiu Zheng,et al. Chimeric RNAs as potential biomarkers for tumor diagnosis. , 2012, BMB reports.
[14] A. Ferrando,et al. The molecular basis of T cell acute lymphoblastic leukemia. , 2012, The Journal of clinical investigation.
[15] M. Gill,et al. Development of Strategies for SNP Detection in RNA-Seq Data: Application to Lymphoblastoid Cell Lines and Evaluation Using 1000 Genomes Data , 2013, PloS one.
[16] Richard Durbin,et al. Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .
[17] A Orfao,et al. Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). , 1995, Leukemia.
[18] Thomas D. Wu,et al. Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events , 2012, Genome research.
[19] K. Khanna,et al. Mutant p53 drives multinucleation and invasion through a process that is suppressed by ANKRD11 , 2012, Oncogene.
[20] Süleyman Cenk Sahinalp,et al. deFuse: An Algorithm for Gene Fusion Discovery in Tumor RNA-Seq Data , 2011, PLoS Comput. Biol..
[21] S. Fan,et al. Proline-Rich Tyrosine Kinase 2 (Pyk2) Promotes Cell Motility of Hepatocellular Carcinoma through Induction of Epithelial to Mesenchymal Transition , 2011, PloS one.
[22] R. Pieters,et al. Biology and treatment of acute lymphoblastic leukemia. , 2008, Pediatric clinics of North America.
[23] Peter Marynen,et al. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32). , 2005, Blood.
[24] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[25] A. Ferrando,et al. Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia , 2004, Nature Genetics.
[26] Kevin P. Murphy,et al. SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors , 2010, Bioinform..
[27] Wei Keat Lim,et al. The transcriptional network for mesenchymal transformation of brain tumors , 2009, Nature.
[28] Stein Aerts,et al. High Accuracy Mutation Detection in Leukemia on a Selected Panel of Cancer Genes , 2012, PloS one.
[29] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[30] Yuchen Jiao,et al. Mutations in CIC and FUBP1 Contribute to Human Oligodendroglioma , 2011, Science.
[31] Jiong Hu,et al. NOTCH1 Mutations in T-Cell Acute Lymphoblastic Leukemia: Prognostic Significance and Implication in Multifactorial Leukemogenesis , 2006, Clinical Cancer Research.
[32] Steven J. M. Jones,et al. Frequent mutation of histone modifying genes in non-Hodgkin lymphoma , 2011, Nature.
[33] Kiran C. Bobba,et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.
[34] B. Nadel,et al. Extensive molecular mapping of TCRα/δ- and TCRβ-involved chromosomal translocations reveals distinct mechanisms of oncogene activation in T-ALL. , 2012, Blood.
[35] A. Hagemeijer,et al. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast , 2006, Leukemia.
[36] Li Ding,et al. Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.
[37] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[38] Rob Pieters,et al. PHF6 mutations in T-cell acute lymphoblastic leukemia , 2010, Nature Genetics.
[39] Cole Trapnell,et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions , 2013, Genome Biology.
[40] Helga Thorvaldsdóttir,et al. Integrative Genomics Viewer , 2011, Nature Biotechnology.
[41] E. Lander,et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. , 2002, Cancer cell.
[42] Charles Lee,et al. Alu elements mediate MYB gene tandem duplication in human T-ALL , 2007, The Journal of experimental medicine.
[43] M. Amylon,et al. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. , 1995, Blood.
[44] J. Soulier,et al. Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia. , 2012, Blood.
[45] W. Vainchenker,et al. JAK/STAT signaling in hematological malignancies , 2013, Oncogene.
[46] Cole Trapnell,et al. Computational methods for transcriptome annotation and quantification using RNA-seq , 2011, Nature Methods.
[47] Brad T. Sherman,et al. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.
[48] David T. W. Jones,et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.
[49] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[50] Hao Yuan Kueh,et al. Regulatory gene network circuits underlying T cell development from multipotent progenitors , 2012, Wiley interdisciplinary reviews. Systems biology and medicine.
[51] J. Pringle,et al. Expression of tenascin-C and its isoforms in the breast , 2010, Cancer and Metastasis Reviews.
[52] Daniel Rios,et al. Bioinformatics Applications Note Databases and Ontologies Deriving the Consequences of Genomic Variants with the Ensembl Api and Snp Effect Predictor , 2022 .
[53] Sandrine Dudoit,et al. GC-Content Normalization for RNA-Seq Data , 2011, BMC Bioinformatics.
[54] Rob Pieters,et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia , 2007, Nature Genetics.
[55] Thomas D. Wu,et al. Deep RNA sequencing analysis of readthrough gene fusions in human prostate adenocarcinoma and reference samples , 2011, BMC Medical Genomics.
[56] Mark D. Robinson,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[57] F. Speleman,et al. Molecular cytogenetic study of 126 unselected T-ALL cases reveals high incidence of TCRβ locus rearrangements and putative new T-cell oncogenes , 2006, Leukemia.
[58] S. Gabriel,et al. Advances in understanding cancer genomes through second-generation sequencing , 2010, Nature Reviews Genetics.
[59] C. Mecucci,et al. New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia. , 2013, Blood.
[60] Yoo Jin Jung,et al. The transcriptional landscape and mutational profile of lung adenocarcinoma , 2012, Genome research.
[61] F. Sigaux,et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). , 2005, Blood.
[62] Anne-Mette K. Hein,et al. Alternative Splicing in Colon, Bladder, and Prostate Cancer Identified by Exon Array Analysis*S , 2008, Molecular & Cellular Proteomics.
[63] L. Feuk,et al. Exome RNA sequencing reveals rare and novel alternative transcripts , 2012, Nucleic acids research.
[64] A. Hall,et al. A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. , 2009, Blood.
[65] J. Maguire,et al. Integrative analysis of the melanoma transcriptome. , 2010, Genome research.
[66] Cole Trapnell,et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. , 2010, Nature biotechnology.
[67] J. Meijerink,et al. Cooperative genetic defects in TLX3 rearranged pediatric T-ALL , 2008, Leukemia.
[68] S. Benitah,et al. From oncogene to tumor suppressor , 2012, Cell cycle.
[69] Li Yang,et al. The difficult calls in RNA editing , 2012, Nature Biotechnology.
[70] Vassilios Ioannidis,et al. ExPASy: SIB bioinformatics resource portal , 2012, Nucleic Acids Res..
[71] Robert B. Hartlage,et al. This PDF file includes: Materials and Methods , 2009 .
[72] Bassem A. Hassan,et al. Gene prioritization through genomic data fusion , 2006, Nature Biotechnology.
[73] Ken Chen,et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data , 2012, Bioinform..
[74] Irmtraud M. Meyer,et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers , 2012, Nature.
[75] Sungjoon Kim,et al. Ba/F3 cells and their use in kinase drug discovery , 2007, Current opinion in oncology.
[76] M. Heinrich,et al. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia , 2012, Leukemia.
[77] David T. W. Jones,et al. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.
[78] S. Mustjoki,et al. Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia. , 2013, Blood.
[79] Peer Bork,et al. SMART 7: recent updates to the protein domain annotation resource , 2011, Nucleic Acids Res..
[80] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[81] S. Fan,et al. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. , 2008, Carcinogenesis.
[82] Steven J. M. Jones,et al. MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers , 2011, Nature.
[83] J Schultz,et al. SMART, a simple modular architecture research tool: identification of signaling domains. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[84] S A Forbes,et al. The Catalogue of Somatic Mutations in Cancer (COSMIC) , 2008, Current protocols in human genetics.
[85] W. J. Kent,et al. BLAT--the BLAST-like alignment tool. , 2002, Genome research.
[86] H. Kulkarni,et al. Association of HADHA expression with the risk of breast cancer: targeted subset analysis and meta-analysis of microarray data , 2012, BMC Research Notes.
[87] A. Takaoka,et al. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway. , 1998, Genes & development.
[88] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.